Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sanjeeva Reddy Onteddu

Concepts (124)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
10
2022
548
3.730
Why?
Fibrinolytic Agents
4
2022
153
1.490
Why?
Thrombolytic Therapy
4
2022
136
1.490
Why?
Tissue Plasminogen Activator
3
2020
128
1.460
Why?
Brain Ischemia
5
2022
165
1.340
Why?
Nervous System Diseases
2
2020
100
1.210
Why?
Thrombectomy
2
2020
62
0.960
Why?
Pneumonia, Viral
3
2020
190
0.900
Why?
Coronavirus Infections
3
2020
199
0.890
Why?
Pandemics
5
2020
565
0.880
Why?
Intracranial Thrombosis
1
2020
23
0.800
Why?
Health Services Misuse
1
2020
16
0.780
Why?
Conflict of Interest
1
2020
25
0.750
Why?
Time-to-Treatment
1
2020
84
0.750
Why?
Patient Transfer
1
2020
111
0.730
Why?
Fabry Disease
1
2019
11
0.720
Why?
Venous Thrombosis
1
2020
110
0.720
Why?
Enzyme Replacement Therapy
1
2019
19
0.720
Why?
Ischemic Attack, Transient
1
2019
59
0.700
Why?
Emergency Service, Hospital
2
2020
537
0.680
Why?
Cardiology
1
2020
106
0.680
Why?
Leukoaraiosis
1
2015
1
0.570
Why?
Recovery of Function
2
2019
232
0.550
Why?
Telemedicine
1
2019
437
0.460
Why?
Hypoxia-Ischemia, Brain
1
2014
65
0.460
Why?
Hospitalization
4
2021
705
0.450
Why?
Heart Arrest
1
2014
148
0.430
Why?
Humans
23
2022
54858
0.400
Why?
Triage
2
2021
80
0.390
Why?
Aged
10
2021
10473
0.390
Why?
Autoimmune Diseases
2
2020
114
0.360
Why?
Retrospective Studies
6
2020
6462
0.360
Why?
Endovascular Procedures
2
2022
191
0.360
Why?
Middle Aged
10
2021
13645
0.350
Why?
Immunosuppressive Agents
2
2020
257
0.340
Why?
Male
13
2021
28269
0.300
Why?
Female
13
2021
29374
0.300
Why?
United States
5
2020
5253
0.300
Why?
Arkansas
4
2019
2231
0.280
Why?
Time Factors
4
2020
3382
0.270
Why?
Tomography, X-Ray Computed
3
2020
1274
0.230
Why?
Treatment Outcome
5
2022
5803
0.230
Why?
Follow-Up Studies
2
2020
2460
0.220
Why?
Carotid-Cavernous Sinus Fistula
1
2022
14
0.220
Why?
Cavernous Sinus
1
2022
18
0.220
Why?
Critical Care
2
2021
230
0.210
Why?
Sinus Thrombosis, Intracranial
1
2021
18
0.210
Why?
Myasthenia Gravis
1
2021
16
0.200
Why?
Neuromuscular Diseases
1
2020
30
0.200
Why?
Embolization, Therapeutic
1
2022
102
0.200
Why?
Iodine Compounds
1
2020
7
0.200
Why?
Health Care Sector
1
2020
17
0.190
Why?
Databases, Factual
2
2020
709
0.190
Why?
Multiple Sclerosis
1
2020
77
0.190
Why?
Drug Industry
1
2020
41
0.190
Why?
Brain Edema
1
2020
40
0.190
Why?
Cohort Studies
2
2022
1576
0.180
Why?
alpha-Galactosidase
1
2019
11
0.180
Why?
Administration, Oral
1
2020
478
0.180
Why?
Disease Outbreaks
1
2020
130
0.180
Why?
Hospitals
1
2020
177
0.180
Why?
Fluorocarbons
1
2019
50
0.180
Why?
Hemorrhage
1
2020
207
0.180
Why?
Medicare
1
2020
230
0.170
Why?
Prevalence
3
2020
1048
0.170
Why?
Contrast Media
1
2020
234
0.170
Why?
Neuroprotective Agents
1
2019
130
0.170
Why?
Coronary Angiography
1
2020
417
0.160
Why?
Pulmonary Disease, Chronic Obstructive
1
2019
135
0.160
Why?
Physicians
1
2020
253
0.150
Why?
Referral and Consultation
1
2019
316
0.150
Why?
Adult
5
2020
14634
0.140
Why?
Plasminogen Activators
1
2015
5
0.140
Why?
Statistics, Nonparametric
1
2015
239
0.140
Why?
Forensic Pathology
1
2014
9
0.130
Why?
Autopsy
1
2014
52
0.130
Why?
Prospective Studies
1
2020
2623
0.130
Why?
Analysis of Variance
1
2015
669
0.120
Why?
Malaria, Falciparum
1
2013
12
0.120
Why?
Optic Neuritis
1
2013
19
0.120
Why?
Health Behavior
1
2014
281
0.110
Why?
Severity of Illness Index
1
2015
1127
0.110
Why?
Aged, 80 and over
2
2019
3607
0.100
Why?
Socioeconomic Factors
1
2014
640
0.100
Why?
Intubation, Intratracheal
2
2021
131
0.090
Why?
Risk Factors
2
2019
4082
0.090
Why?
Magnetic Resonance Imaging
1
2015
1699
0.080
Why?
Intracranial Hemorrhages
1
2022
44
0.060
Why?
Cerebral Hemorrhage
1
2022
103
0.050
Why?
Headache
1
2022
81
0.050
Why?
Cranial Sinuses
1
2021
11
0.050
Why?
Arthritis, Psoriatic
1
2020
11
0.050
Why?
Spondylitis, Ankylosing
1
2020
11
0.050
Why?
Disease Susceptibility
1
2021
98
0.050
Why?
Colitis, Ulcerative
1
2020
55
0.050
Why?
Osmolar Concentration
1
2020
84
0.050
Why?
Infarction, Middle Cerebral Artery
1
2020
42
0.050
Why?
Neurologic Examination
1
2020
75
0.050
Why?
Mortality
1
2020
109
0.050
Why?
Maximum Tolerated Dose
1
2019
37
0.050
Why?
Crohn Disease
1
2020
96
0.050
Why?
Arthritis, Rheumatoid
1
2020
133
0.050
Why?
Neuroimaging
1
2020
98
0.050
Why?
Tertiary Care Centers
1
2019
90
0.050
Why?
Subarachnoid Hemorrhage
1
2020
63
0.050
Why?
Registries
1
2022
574
0.050
Why?
Administration, Intravenous
1
2019
82
0.050
Why?
Drug-Eluting Stents
1
2020
115
0.040
Why?
Electronic Health Records
1
2021
179
0.040
Why?
Disability Evaluation
1
2019
111
0.040
Why?
Drug Administration Schedule
1
2019
418
0.040
Why?
Comorbidity
1
2019
699
0.040
Why?
Patient Readmission
1
2019
247
0.040
Why?
Double-Blind Method
1
2019
756
0.040
Why?
Diagnosis, Differential
1
2020
1179
0.040
Why?
Myocardial Infarction
1
2020
463
0.030
Why?
Percutaneous Coronary Intervention
1
2020
346
0.030
Why?
Risk Assessment
1
2019
1416
0.030
Why?
Cross-Sectional Studies
1
2019
1694
0.030
Why?
Antimalarials
1
2013
30
0.030
Why?
Infant
1
2020
3798
0.030
Why?
Child, Preschool
1
2020
4179
0.030
Why?
Adolescent
1
2020
7022
0.020
Why?
Child
1
2020
7280
0.020
Why?
Onteddu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description